People under the age of 40 in the U.K. are to be offered an alternative to the Oxford-AstraZeneca Covid-19 vaccine, as concerns over links to rare blood clots continue to weigh on its roll out. Speaking at a press conference on Friday, Professor Wei Shen Lim, chair of the U.K.’s Joint Committee on Vaccination and […] Read more
LONDON — The coronavirus vaccine being developed by AstraZeneca and the University of Oxford is expected to be approved for use in the U.K. in coming days. The Financial Times reported Sunday that government officials confirmed that the Medicines and Healthcare products Regulatory Agency would imminently approve the vaccine, saying the announcement could come as soon as Tuesday. The […] Read more
